Amy, 30
Preschool teacher
"My migraine comes back over the course of a day, especially during my period."
Amy, 30
Amy has suffered from migraines, both during and outside her period, for 5 years, causing her to miss work about 1 day every couple of months. Her migraine frequently recurs during a 24 hour period.
Current migraine treatment
Uses prescription drugs, but reports that migraines frequently recur, causing redosing
Learn how FROVA® may help reduce the recurrence of migraines
Maria, 23
Full-time graduate student
"I'm concerned about the side effects of prescription drugs, especially since I'm currently using oral contraceptives."
Maria, 23
Maria suffers from migraines during and outside her period. She misses at least 1 day of classes each month because of migraines. Maria's doctor recommended a prescription medication for migraine, but she is concerned about interactions with oral contraceptives.
Current migraine treatment
Uses over-the-counter drugs, but is not satisfied with the relief she's getting for migraines around her period
Learn how FROVA® may provide migraine pain relief around the time of your period
Lisa, 41
Stay-at-home mom with twin boys
"I usually get moderate or debilitating migraines around the time of my period."
Lisa, 41
Lisa recently started getting more severe migraines around the time of her period, which cause her to miss her carpooling turn about once a month. Sometimes her migraines are so debilitating, she's forced to cancel plans with the family.
Current migraine treatment
Uses prescription drugs, but must redose to relieve her moderate-to-severe migraines
Learn how FROVA® may provide migraine pain relief with just a single pill
The most common side effects associated with the use of FROVA are dizziness, tiredness, feeling of tingling, hot flashes, headache (other than migraine headache), dry mouth, hot or cold sensation, pain in joints or bones, chest pain, and indigestion.
+ View references
- Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd ed. Cephalalgia. 2004;24(suppl 1):24-36; 138-149. Available at: http://216.25.100.131/ihscommon/guidelines/pdfs/ihc_II_main_no_print.pdf. Accessed January 19, 2007.
- American Council for Headache Education. Headache diary. Available at: http://www.achenet.org/resources/diary.php. Accessed February 21, 2007.
- National Headache Foundation. Serotonin. Available at: http://www.headaches.org/consumer/topicsheets/serotonin.html. Accessed February 21, 2007.
- American Council for Headache Education. Women and headaches. Available at: http://www.achenet.org/news/women.php. Accessed February 21, 2007.
- American Council for Headache Education. Migraine and coexisting conditions. Available at: http://www.achenet.org/news/macc.php. Accessed February 21, 2007.
- Lichten EM, Lichten JB, Whitty A, Pieper D. The confirmation of a biochemical marker for women's hormonal migraine: the Depo-Estradiol challenge test. Headache. 1996;36:367-371.
- MacGregor EA. Oestrogen and attacks of migraine with and without aura. Lancet Neurol. 2004;3:354-361.
- Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646-657.
- Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache. 1993;33:385-389.
- Dzoljic E, Sipetic S, Vlajinac H, et al. Prevalence of menstrually related migraine and nonmigraine primary headache in female students of Belgrade University. Headache. 2002;42:185-193.
- Granella F, Sances G, Allais G, et al. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia. 2004;24:707-716.
- Couturier EGM, Bomhof MAM, Knuistingh Neven A, van Duijn NP. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia. 2003;23:302-308.
- MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology. 2004;63:351-353.
- Martin VT, Wernke S, Mandell K, et al. Defining the relationship between ovarian hormones and migraine headache. Headache. 2005;45:1190-1201.
- MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology. 2006;67(72):2154-2158. doi: 10.1212/01.wnl.0000233888.18228.19.
- Silberstein SD, Elkind AH, Schreiber C, Keywood C. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology. 2004;63:261-269.
- Silberstein SD. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000; 55:754-762.
- Cady R, Elkind A, Goldstein J, Keywood C. Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe. Curr Res Med Opin. 2004; 20(9):1465-1472. doi: 10.1185/030079904x2745.
- FROVA® [package insert]. Chadds Ford, PA: Endo Pharmaceuticals; 2007.
- Kelman L. Pain characteristics of the acute migraine attack. Headache. 2006;46(6):942-953. doi:10.1111/j.1526-4610.2006.00443.x.
- Malik SN, Hopkins M, Young WB, Silberstein SD. Acute migraine treatment: patterns of use and satisfaction in a clinical population. Headache. 2006;46(5):773-780. doi:10.1111/j.1526-4610.2006.00437.x.
- Guidelines for controlled trials of drugs in migraine. First edition. International Headache Society Committee on Clinical Trials in Migraine. Cephalalgia. 1991;11(1):1-12.
- FROVA® Patient Product Information. Chadds Ford, PA: Endo Pharmaceuticals; 2007.